What Is MRSA and How Do You Get It: Symptoms

MRSA (methicillin-resistant Staphylococcus aureus) is a type of staph bacteria that has developed resistance to many common antibiotics, making infections harder to treat. About 2 in every 100 people carry MRSA on their skin or in their nose without ever getting sick. When it does cause infection, it spreads primarily through skin-to-skin contact and contact with contaminated surfaces or shared items.

Why MRSA Resists Common Antibiotics

Staphylococcus aureus is a common bacterium. Many people carry it harmlessly. Regular staph infections respond to standard antibiotics called beta-lactams, which work by binding to proteins the bacteria need to build their cell walls. Without functional cell walls, the bacteria break apart and die.

MRSA strains carry an extra piece of genetic material, a gene called mecA, that produces an altered version of the protein these antibiotics target. Because the altered protein doesn’t bind well to the drugs, the bacteria keep building their cell walls even when antibiotics are present. This resistance isn’t something MRSA develops during your infection. The bacteria acquired this genetic change and pass it along to new generations, which is why MRSA persists as a distinct problem separate from ordinary staph.

How MRSA Spreads

MRSA moves between people in two main ways: direct skin-to-skin contact and touching contaminated surfaces or objects. The bacteria can survive on surfaces like towels, razors, athletic equipment, and doorknobs, then enter the body through cuts, scrapes, or other breaks in the skin.

Several conditions make transmission more likely. Crowded environments bring people into closer physical contact. Shared items like towels, uniforms, or workout equipment pass bacteria between users. Broken or compromised skin gives MRSA a way in. Poor hygiene allows bacteria to accumulate. These factors explain why MRSA outbreaks commonly occur in places like locker rooms, military barracks, dormitories, and daycare facilities.

Community MRSA vs. Hospital MRSA

MRSA infections fall into two broad categories depending on where a person picks them up, and the two types behave differently.

Community-associated MRSA (CA-MRSA) affects people with no recent history of hospitalization, surgery, dialysis, or residence in a long-term care facility. It tends to strike younger, otherwise healthy people. The vast majority of CA-MRSA infections show up as skin and soft tissue problems: boils, abscesses, and cellulitis. In rare cases, it can cause more serious conditions like joint infections, severe pneumonia, or bloodstream infections. One notable feature of community strains is that they often remain susceptible to a wider range of antibiotics than their hospital counterparts.

Healthcare-associated MRSA (HA-MRSA) occurs in people who have been in hospitals or other medical settings. Patients with surgical wounds, IV lines, catheters, or weakened immune systems face higher risk. HA-MRSA strains tend to be resistant to more antibiotic classes, which narrows treatment options. Bloodstream infections acquired in hospitals carry a mortality rate near 29%, compared to about 18% for community-onset cases.

What MRSA Infections Look and Feel Like

Most MRSA infections appear on the skin. A typical infection starts as a bump or area that is red, swollen, painful, and warm to the touch. It often fills with pus or produces drainage and may be accompanied by fever. Many people mistake early MRSA skin infections for spider bites, but unless you actually saw a spider bite you, a painful red bump is far more likely to be a staph infection.

Skin infections that go untreated can progress. The bacteria can move deeper into the body, causing bone and joint infections, pneumonia, or bloodstream infections (sepsis). In 2017, an estimated 119,247 staph bloodstream infections occurred in the United States, resulting in nearly 20,000 deaths. The overall in-hospital mortality rate for staph bloodstream infections was 18%. These severe outcomes are uncommon when skin infections are caught and treated early, but they illustrate why MRSA shouldn’t be ignored.

Carrying MRSA Without Knowing It

Colonization and infection are different things. About 2% of the general population carries MRSA, typically in the nose or on the skin, without any symptoms. Certain groups, including healthcare workers and people who have been hospitalized recently, carry it at higher rates. Being colonized doesn’t mean you’re sick, but it does mean you can spread the bacteria to others and that you’re at increased risk of developing an active infection if your skin barrier is broken or your immune system is weakened.

How MRSA Is Treated

Because MRSA doesn’t respond to the standard antibiotics used for ordinary staph, treatment depends on how severe the infection is. Minor skin infections like small abscesses are often treated by draining the pus, sometimes without antibiotics at all. For infections that need medication, doctors can prescribe oral antibiotics that still work against community MRSA strains.

Serious or invasive MRSA infections require intravenous antibiotics, most commonly vancomycin, which has been the traditional backbone of MRSA treatment. For bloodstream infections that don’t respond within a few days, doctors may combine medications or switch to alternative agents. Severe infections like those affecting heart valves or bones can require weeks of IV therapy. Treatment has become more nuanced in recent years as some MRSA strains have developed reduced sensitivity even to vancomycin, pushing clinicians toward newer options.

Reducing Your Risk

Prevention comes down to basic hygiene practiced consistently. Wash your hands frequently with soap and water. Keep cuts, scrapes, and wounds clean and covered with a bandage until they heal. Avoid sharing personal items like towels, razors, and clothing.

In gyms and athletic settings, clean shared equipment after each use and let it dry before the next person uses it. Standard household bleach diluted in water (a quarter cup of regular bleach per gallon) is effective at killing MRSA on surfaces, as are EPA-registered disinfectants. Equipment with damaged or cracked surfaces that can’t be properly cleaned should be repaired or replaced. Large-scale spraying or fogging of disinfectants hasn’t been shown to work better than simply cleaning the surfaces people actually touch.

Hospital-acquired MRSA rates have dropped significantly over the past two decades. From 2005 to 2012, hospital-onset MRSA bloodstream infections declined by about 17% per year, though that pace slowed after 2012 to about 7% annually. Community-onset MRSA rates, by contrast, have plateaued, reinforcing the importance of personal prevention habits outside of healthcare settings.